VIROPRO INC (OTCMKTS:VPRO) Short Interest Decreased By 9.52%

June 14, 2018 - By reb123z

Viropro Inc. (OTCMKTS:VPRO) Logo

The stock of VIROPRO INC (OTCMKTS:VPRO) registered a decrease of 9.52% in short interest. VPRO’s total short interest was 3,800 shares in June as published by FINRA. Its down 9.52% from 4,200 shares, reported previously. With 29,200 shares average volume, it will take short sellers 0 days to cover their VPRO’s short positions.

The stock increased 6.67% or $0.0002 during the last trading session, reaching $0.0032. About 1.05 million shares traded or 106.47% up from the average. Viropro Inc. (OTCMKTS:VPRO) has 0.00% since June 14, 2017 and is . It has underperformed by 12.57% the S&P500.

Viropro Inc., through its subsidiaries, engages in the contract research, development, and manufacture of biotherapeutic proteins for the treatment of various diseases. The company has market cap of $4.07 million. The firm is also involved in the transfer of its proprietary technologies for industrial production of biogeneric therapeutic proteins for the treatment of various diseases, such as cancer, diabetes, hepatitis, or multiple sclerosis. It currently has negative earnings. It makes biologics drugs, including bio-similars for pre-clinical, and Phase I, II, and III clinical trials; offers its clients with supply of mammalian cell proteins, such as monoclonal antibodies or recombinant proteins, or other cell-derived products; owns three clones that include two in insulin therapy and one for cancer therapy; and provides contractual research and manufacturing services to biotech and biopharmaceutical companies.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: